Fund moves

Veracyte, Inc. (VCYT): ARK Investment Management added to its stake +669K shares

ARK Investment Management added to its stake in Veracyte, Inc., per its Q3 2026 13F.

2.96M
Shares reported · +669K vs prior quarter
0.79%
Disclosed portfolio weight
$136M
Reported value
Holdings as of
Sep 30, 2026
Filed
Nov 13, 2026

What stands out in this filing

  • 2,295,951 shares in Q2 2026, 2,964,650 now (+29.1% in share count).
  • Reported at $136M, 0.79% of the portfolio value in this 13F filing.
  • No other tracked manager reported the same kind of change for Q3 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2025Federal contract · $130K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $130K obligated to date
  2. Jan 8, 2026Federal contract · $345K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $345K obligated to date
  3. Sep 10, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 1 more item)“On September 14, 2026, Veracyte completed its acquisition of Convergent pursuant to the terms of the Merger Agreement. To the extent required by this Item 2.01, the information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this”
  4. Sep 24, 2026InsiderDirector sold ~$353K of VCYT shares in the open market
  5. Oct 19, 2026InsiderDirector sold ~$81K of VCYT shares in the open market
  6. Oct 27, 2026Insider · 2 peopleInsiders: 2 sales (~$1.1M)
  7. Nov 4, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  8. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 7.7%
  9. Nov 12, 20265% stakeArtisan Partners Asset Management Inc. reported a passive stake (13G) of 2.9%
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Veracyte, Inc.

For Veracyte, Inc., OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VCYT page.

How this filing works

Explore the data

Common questions

What does this filing report about Veracyte, Inc. (VCYT) stock?

ARK Investment Management added to its stake in Veracyte, Inc., per its Q3 2026 13F. Now 2.96M shares, $136M reported value, 0.79% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2026. Filed: Nov 13, 2026.

What stands out in this filing?

2,295,951 shares in Q2 2026, 2,964,650 now (+29.1% in share count). Reported at $136M, 0.79% of the portfolio value in this 13F filing. No other tracked manager reported the same kind of change for Q3 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Veracyte, Inc. recently?

For Veracyte, Inc., OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the VCYT page.

Does this mean VCYT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Veracyte, Inc.

Everything OQRO holds on this company is on its VCYT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data